March 2018 – Bariatric News

A drug-free approach might be the best treatment we have for America’s most ubiquitous lifestyle disease.

Source: Is Keto the Cure for Type II Diabetes?

Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity November 23, 2020

Obesity is a risk factor for poor clinical outcomes in patients with coronavirus disease 2019 (COVID-19).

Ali Aminian, Alisan Fathalizadeh, Chao Tu, W. Scott Butsch, Kevin M. Pantalone, Marcio L. Griebeler, Sangeeta R. Kashyap, Raul J. Rosenthal, Bartolome Burguera, Steven E. Nissen

The Use of Non-steroidal Anti-inflammatory Drugs After Sleeve Gastrectomy November 20, 2020

The use of non-steroidal anti-inflammatory drugs (NSAIDs) are discouraged after bariatric surgery. The effect of NSAIDs on patients who have undergone sleeve gastrectomy (SG) is not well studied. Moreover, the rate of NSAID use after SG is unknown.

Alan Begian, Jamil S. Samaan, Lauren Hawley, Evan T. Alicuben, Angelica Hernandez, Kamran Samakar

Impact of metabolic surgery on 10-year cardiovascular disease risk in Chinese individuals with type 2 diabetes November 19, 2020

In recent years, many reports highlight that metabolic surgery may ameliorate cardiovascular risk in morbid obese patients with or without type 2 diabetes mellitus (T2DM). However, few studies have evaluated long-term cardiovascular disease (CVD) risk after metabolic surgery in low body mass index (BMI) T2DM patients.

Zhigang Ke, Fan Li, Xunmei Zhou, Fang Sun, Zhiming Zhu, Weidong Tong

Hospitalizations and Emergency Department Visits in Heart Failure Patients after Bariatric Surgery November 19, 2020

Heart failure is a disease with significant healthcare utilization, and a prioritized target for readmission prevention. Although obesity is related to heart failure morbidity, the effects of bariatric surgery in obese patients with heart failure are not well studied.

Stella T. Tsui, Jie Yang, Xiaoyue Zhang, Salvatore Docimo, Konstantinos Spaniolas, Aurora D. Pryor

The metabolic and liver-related outcomes of bariatric surgery in adult patients with insulin-treated type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) at high risk of liver fibrosis November 19, 2020

To investigate the metabolic and liver-related outcomes of bariatric surgery among patients with insulin-treated type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD) who are at high risk of liver fibrosis.

Mohammed Alkharaiji, Uchenna Anyanwagu, Thomas Crabtree, Iskandar Idris

Month: March 2018

4 reasons you’re always hungry

Is Keto the Cure for Type II Diabetes?